226 related articles for article (PubMed ID: 27571708)
1. Silencing Aurora-A with siRNA inhibits cell proliferation in human lung adenocarcinoma cells.
Zhong N; Shi S; Wang H; Wu G; Wang Y; Ma Q; Wang H; Liu Y; Wang J
Int J Oncol; 2016 Sep; 49(3):1028-38. PubMed ID: 27571708
[TBL] [Abstract][Full Text] [Related]
2. Knocking down the expression of Aurora-A gene inhibits cell proliferation and induces G2/M phase arrest in human small cell lung cancer cells.
Lu Y; Liu Y; Jiang J; Xi Z; Zhong N; Shi S; Wang J; Wei X
Oncol Rep; 2014 Jul; 32(1):243-9. PubMed ID: 24841948
[TBL] [Abstract][Full Text] [Related]
3. Silencing of Aurora kinase A by RNA interference inhibits tumor growth in human osteosarcoma cells by inducing apoptosis and G2/M cell cycle arrest.
Jiang Z; Jiang J; Yang H; Ge Z; Wang Q; Zhang L; Wu C; Wang J
Oncol Rep; 2014 Mar; 31(3):1249-54. PubMed ID: 24452445
[TBL] [Abstract][Full Text] [Related]
4. Aurora kinase targeting in lung cancer reduces KRAS-induced transformation.
Dos Santos EO; Carneiro-Lobo TC; Aoki MN; Levantini E; Bassères DS
Mol Cancer; 2016 Feb; 15():12. PubMed ID: 26842935
[TBL] [Abstract][Full Text] [Related]
5. Aurora-A-mediated phosphorylation of LKB1 compromises LKB1/AMPK signaling axis to facilitate NSCLC growth and migration.
Zheng X; Chi J; Zhi J; Zhang H; Yue D; Zhao J; Li D; Li Y; Gao M; Guo J
Oncogene; 2018 Jan; 37(4):502-511. PubMed ID: 28967900
[TBL] [Abstract][Full Text] [Related]
6. Aurora A kinase and its activator TPX2 are potential therapeutic targets in KRAS-induced pancreatic cancer.
Gomes-Filho SM; Dos Santos EO; Bertoldi ERM; Scalabrini LC; Heidrich V; Dazzani B; Levantini E; Reis EM; Bassères DS
Cell Oncol (Dordr); 2020 Jun; 43(3):445-460. PubMed ID: 32193808
[TBL] [Abstract][Full Text] [Related]
7. NCAPG2 promotes tumour proliferation by regulating G2/M phase and associates with poor prognosis in lung adenocarcinoma.
Zhan P; Xi GM; Zhang B; Wu Y; Liu HB; Liu YF; Xu WJ; Zhu Q; Cai F; Zhou ZJ; Miu YY; Wang XX; Jin JJ; Li Q; Lv TF; Song Y
J Cell Mol Med; 2017 Apr; 21(4):665-676. PubMed ID: 27862966
[TBL] [Abstract][Full Text] [Related]
8. Daurinol Enhances the Efficacy of Radiotherapy in Lung Cancer via Suppression of Aurora Kinase A/B Expression.
Woo JK; Kang JH; Shin D; Park SH; Kang K; Nho CW; Seong JK; Lee SJ; Oh SH
Mol Cancer Ther; 2015 Jul; 14(7):1693-704. PubMed ID: 25882311
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.
Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D
Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929
[TBL] [Abstract][Full Text] [Related]
10. Local injection of lentivirus-delivered livinshRNA suppresses lung adenocarcinoma growth by inducing a G0/G1 phase cell cycle arrest.
Chen YS; Li HR; Miao Y; Chen WY; Li YT; Wang GQ; Wu ZC
Int J Clin Exp Pathol; 2012; 5(8):796-805. PubMed ID: 23071862
[TBL] [Abstract][Full Text] [Related]
11. MID1-PP2A complex functions as new insights in human lung adenocarcinoma.
Zhang L; Li J; Lv X; Guo T; Li W; Zhang J
J Cancer Res Clin Oncol; 2018 May; 144(5):855-864. PubMed ID: 29450633
[TBL] [Abstract][Full Text] [Related]
12. Low expression of PTEN is essential for maintenance of a malignant state in human gastric adenocarcinoma via upregulation of p‑AURKA mediated by activation of AURKA.
Li L; Song Y; Liu Q; Liu X; Wang R; Kang C; Zhang Q
Int J Mol Med; 2018 Jun; 41(6):3629-3641. PubMed ID: 29512701
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Aurora A enhances radiosensitivity in selected lung cancer cell lines.
Liu N; Wang YA; Sun Y; Ecsedy J; Sun J; Li X; Wang P
Respir Res; 2019 Oct; 20(1):230. PubMed ID: 31647033
[TBL] [Abstract][Full Text] [Related]
14. Activation of EIF4E by Aurora Kinase A Depicts a Novel Druggable Axis in Everolimus-Resistant Cancer Cells.
Katsha A; Wang L; Arras J; Omar OM; Ecsedy J; Belkhiri A; El-Rifai W
Clin Cancer Res; 2017 Jul; 23(14):3756-3768. PubMed ID: 28073841
[No Abstract] [Full Text] [Related]
15. Lentivirus-delivered ZEB-1 small interfering RNA inhibits lung adenocarcinoma cell growth in vitro and in vivo.
Liu Y; Yan X; Liu N; Zhou J; Liu J; Pang H; Cao J; Liu Y; Wang Y; Liu L; Zhang H
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1329-38. PubMed ID: 22481253
[TBL] [Abstract][Full Text] [Related]
16. Effects of TGF-β signaling blockade on human A549 lung adenocarcinoma cell lines.
Xu CC; Wu LM; Sun W; Zhang N; Chen WS; Fu XN
Mol Med Rep; 2011; 4(5):1007-15. PubMed ID: 21725601
[TBL] [Abstract][Full Text] [Related]
17. Expression profile‑driven discovery of AURKA as a treatment target for liposarcoma.
Yen CC; Chen SC; Hung GY; Wu PK; Chua WY; Lin YC; Yen CH; Chen YC; Wang JY; Yang MH; Chao Y; Chang MC; Chen WM
Int J Oncol; 2019 Oct; 55(4):938-948. PubMed ID: 31485600
[TBL] [Abstract][Full Text] [Related]
18. Effect of AURKA Gene Expression Knockdown on Angiogenesis and Tumorigenesis of Human Ovarian Cancer Cell Lines.
Wang C; Yan Q; Hu M; Qin D; Feng Z
Target Oncol; 2016 Dec; 11(6):771-781. PubMed ID: 27250762
[TBL] [Abstract][Full Text] [Related]
19. Repression of the AURKA-CXCL5 axis induces autophagic cell death and promotes radiosensitivity in non-small-cell lung cancer.
Wang J; Hu T; Wang Q; Chen R; Xie Y; Chang H; Cheng J
Cancer Lett; 2021 Jul; 509():89-104. PubMed ID: 33848520
[TBL] [Abstract][Full Text] [Related]
20. Tanshinones suppress AURKA through up-regulation of miR-32 expression in non-small cell lung cancer.
Ma ZL; Zhang BJ; Wang DT; Li X; Wei JL; Zhao BT; Jin Y; Li YL; Jin YX
Oncotarget; 2015 Aug; 6(24):20111-20. PubMed ID: 26036635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]